These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 21681091)
1. Cardiovascular disease and ovarian function. Kallen AN; Pal L Curr Opin Obstet Gynecol; 2011 Aug; 23(4):258-67. PubMed ID: 21681091 [TBL] [Abstract][Full Text] [Related]
2. A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement. Stevenson JC Maturitas; 2011 Oct; 70(2):197-205. PubMed ID: 21788109 [TBL] [Abstract][Full Text] [Related]
4. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy. Antonicelli R; Olivieri F; Morichi V; Urbani E; Mais V Int J Cardiol; 2008 Nov; 130(2):140-6. PubMed ID: 18617278 [TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system? Rosano GM; Vitale C; Fini M Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159 [TBL] [Abstract][Full Text] [Related]
6. Hormones and cardiovascular health in women. ESHRE Capri Workshop Group Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276 [TBL] [Abstract][Full Text] [Related]
7. DHEA, important source of sex steroids in men and even more in women. Labrie F Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662 [TBL] [Abstract][Full Text] [Related]
8. Sex steroids and breast cancer prevention. Spicer DV; Pike MC J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456 [TBL] [Abstract][Full Text] [Related]
9. Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones. Rossouw JE Maturitas; 2005 May; 51(1):51-63. PubMed ID: 15883110 [TBL] [Abstract][Full Text] [Related]
10. The adverse effects of hormonal therapy. Bush TL Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931 [TBL] [Abstract][Full Text] [Related]
11. Prognostic features of menopausal and postmenopausal applicants for life insurance. Schiefeling M J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866 [TBL] [Abstract][Full Text] [Related]
12. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer. van Leeuwen FE Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500 [TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular disease as a current threat of older women. Relation to estrogens]. Zárate A; Saucedo R; Basurto L; Martínez C Ginecol Obstet Mex; 2007 May; 75(5):286-92. PubMed ID: 17849811 [TBL] [Abstract][Full Text] [Related]
15. Oestrogens and the heart. Rosano GM; Panina G Therapie; 1999; 54(3):381-5. PubMed ID: 10500455 [TBL] [Abstract][Full Text] [Related]
16. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
17. Aging, menopause, and free radicals. Schwenke DC Semin Reprod Endocrinol; 1998; 16(4):281-308. PubMed ID: 10101810 [TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone therapy and the risk of cardiovascular disease. Stramba-Badiale M J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340 [TBL] [Abstract][Full Text] [Related]
19. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast. Wang PH; Horng HC; Cheng MH; Chao HT; Chao KC Taiwan J Obstet Gynecol; 2007 Jun; 46(2):127-34. PubMed ID: 17638620 [TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. Ouyang P; Michos ED; Karas RH J Am Coll Cardiol; 2006 May; 47(9):1741-53. PubMed ID: 16682298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]